本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovoCure Limited

12.33
+0.30502.54%
盘前12.24-0.0900-0.73%04:05 EDT
成交量:101.45万
成交额:1,249.45万
市值:13.78亿
市盈率:-7.90
高:12.47
开:12.06
低:12.05
收:12.03
52周最高:34.13
52周最低:10.87
股本:1.12亿
流通股本:9,414.79万
量比:0.74
换手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-1.5604
每股收益(LYR):-1.5638
净资产收益率:-48.07%
总资产收益率:-8.64%
市净率:3.94
市盈率(LYR):-7.88

数据加载中...

2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/10/30

重要事件披露

Form 8-K - Current report